OK SB 1025
died on adjournmentHealth care; creating the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025; clarifying authority to take certain actions. Effective date.
Oklahoma · 2026 Regular Session · upper
Quick answers
Did OK SB 1025 pass?
No. OK SB 1025 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-02-11): Coauthored by Representative Bashore (principal House author)
What is OK SB 1025 about?
OK SB 1025 is a bill in the 2026 Regular Session titled “Health care; creating the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025; clarifying authority to take certain actions. Effective date.”.
Who sponsors OK SB 1025?
Haste, Bashore are the primary sponsors of OK SB 1025.
- Introduced
- 2025-02-03
- Latest action
- 2025-02-11 — Coauthored by Representative Bashore (principal House author)
- Bill type
- bill
- Last updated
- —
Sponsors
- Hasteprimary
- Bashoreprimary
Committees
Not provided by source.
Action timeline
2025-02-03
First Reading
introduction,reading-1
2025-02-03
Authored by Senator Haste
2025-02-04
Second Reading referred to Business and Insurance
reading-2,referral-committee
2025-02-11
Coauthored by Representative Bashore (principal House author)
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:30:20.811026Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=OK&identifier=SB 1025. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.